BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23087323)

  • 1. Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules.
    Walsh PS; Wilde JI; Tom EY; Reynolds JD; Chen DC; Chudova DI; Pagan M; Pankratz DG; Wong M; Veitch J; Friedman L; Monroe R; Steward DL; Lupo MA; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2297-306. PubMed ID: 23087323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules.
    Hao Y; Choi Y; Babiarz JE; Kloos RT; Kennedy GC; Huang J; Walsh PS
    Front Endocrinol (Lausanne); 2019; 10():438. PubMed ID: 31333584
    [No Abstract]   [Full Text] [Related]  

  • 3. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
    Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides.
    Benjamin H; Schnitzer-Perlman T; Shtabsky A; VandenBussche CJ; Ali SZ; Kolar Z; Pagni F; ; Bar D; Meiri E
    Cancer Cytopathol; 2016 Oct; 124(10):711-721. PubMed ID: 27223344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter clinical experience with the Afirma gene expression classifier.
    Alexander EK; Schorr M; Klopper J; Kim C; Sipos J; Nabhan F; Parker C; Steward DL; Mandel SJ; Haugen BR
    J Clin Endocrinol Metab; 2014 Jan; 99(1):119-25. PubMed ID: 24152684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience.
    Wei S; Veloski C; Sharda P; Ehya H
    Cancer Cytopathol; 2019 Nov; 127(11):720-724. PubMed ID: 31536167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance of a bronchial genomic classifier.
    Hu Z; Whitney D; Anderson JR; Cao M; Ho C; Choi Y; Huang J; Frink R; Smith KP; Monroe R; Kennedy GC; Walsh PS
    BMC Cancer; 2016 Feb; 16():161. PubMed ID: 26920854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
    Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical diagnostic gene expression thyroid testing.
    Steward DL; Kloos RT
    Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
    Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of thyroid nodules using high-dimensionality genomic data.
    Chudova D; Wilde JI; Wang ET; Wang H; Rabbee N; Egidio CM; Reynolds J; Tom E; Pagan M; Rigl CT; Friedman L; Wang CC; Lanman RB; Zeiger M; Kebebew E; Rosai J; Fellegara G; LiVolsi VA; Kennedy GC
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5296-304. PubMed ID: 20826580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
    Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usage trends and performance characteristics of a "gene expression classifier" in the management of thyroid nodules: An institutional experience.
    Samulski TD; LiVolsi VA; Wong LQ; Baloch Z
    Diagn Cytopathol; 2016 Nov; 44(11):867-873. PubMed ID: 27534929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Afirma Gene Sequencing Classifier versus Gene Expression Classifier in thyroid nodules with indeterminate cytology.
    Yang Z; Zhang T; Layfield L; Esebua M
    J Am Soc Cytopathol; 2022; 11(2):74-78. PubMed ID: 34366280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
    Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
    N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.
    Eszlinger M; Hegedüs L; Paschke R
    Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules.
    San Martin VT; Lawrence L; Bena J; Madhun NZ; Berber E; Elsheikh TM; Nasr CE
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Afirma Gene Expression Classifier Result on the Surgical Management of Thyroid Nodules with Category III/IV Cytology and Its Correlation with Surgical Outcome.
    Chaudhary S; Hou Y; Shen R; Hooda S; Li Z
    Acta Cytol; 2016; 60(3):205-10. PubMed ID: 27344463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.